Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Everest Medicines Ltd. (HK:1952)
HKEX:1952
Holding HK:1952?
Track your performance easily
See the Price Targets and Ratings of:
1952 Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
1952 Stock 12 Month Forecast
Average Price Target
HK$25.00
▼(-28.88% Downside)
| Highest Price TargetHK$25.00 | Average Price TargetHK$25.00 | Lowest Price TargetHK$25.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Goldman Sachs
Reiterated
11/26/23
―
Citi
―
Hold
―
Reiterated
08/28/24
Everest Medicines Ltd (1952:HK) PT Lowered to HK$25 at CitiCiti analyst Wangbin Zhou lowered the price target on Everest Medicines Ltd (1952:HK) to HK$25.00 (from HK$27.00) while maintaining a Neutral rating.
1952 Analyst Recommendation Trends
Rating
Apr 23
Aug 23
Sep 23
Nov 23
Aug 24
Strong Buy
2
2
1
0
0
Buy
0
0
0
0
0
Hold
3
3
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
4
3
3
Each month's total comprises the sum of three months' worth of ratings.
1952 Financial Forecast
1952 Stock Forecast FAQ
What is HK:1952’s average 12-month price target, according to analysts?
Based on analyst ratings, Everest Medicines Ltd.’s 12-month average price target is HK$25.00.
What is HK:1952’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1952, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Everest Medicines Ltd. a Buy, Sell or Hold?
Everest Medicines Ltd. has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Everest Medicines Ltd.’s share price target?
The average share price target for Everest Medicines Ltd. is HK$25.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$25.00 ,and the lowest forecast is HK$25.00. The average share price target represents -28.88% Decrease from the current price of HK$35.15.
The highest analyst share price target is HK$25.00 ,and the lowest forecast is HK$25.00. The average share price target represents -28.88% Decrease from the current price of HK$35.15.
What do analysts say about Everest Medicines Ltd.?
Everest Medicines Ltd.’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Everest Medicines Ltd.?
To buy shares of HK:1952, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.